Unknown

Dataset Information

0

Repeated tender point injections of granisetron alleviate chronic myofascial pain--a randomized, controlled, double-blinded trial.


ABSTRACT: Serotonin (5-HT) mediates pain by peripheral 5-HT3-receptors. Results from a few studies indicate that intramuscular injections of 5-HT3-antagonists may reduce musculoskeletal pain. The aim of this study was to investigate if repeated intramuscular tender-point injections of the 5-HT3-antagonist granisetron alleviate pain in patients with myofascial temporomandibular disorders (M-TMD).This prospective, randomized, controlled, double blind, parallel-arm trial (RCT) was carried out during at two centers in Stockholm, Sweden. The randomization was performed by a researcher who did not participate in data collection with an internet-based application ( www.randomization.com ). 40 patients with a diagnose of M-TMD according to the Research Diagnostic Criteria for Temporomandibular Disorders (RDC/TMD) were randomized to receive repeated injections, one week apart, with either granisetron (GRA; 3 mg) or isotonic saline as control (CTR).The median weekly pain intensities decreased significantly at all follow-ups (1-, 2-, 6-months) in the GRA-group (Friedman test; P??0.075). The numbers needed to treat (NNT) were 4 at the 1- and 6-month follow-ups, and 3.3 at the 2-month follow-up in favor of granisetron.Repeated intramuscular tender-point injections with granisetron provide a new pharmacological treatment possibility for myofascial pain patients with repeated intramuscular tender-point injections with the serotonin type 3 antagonist granisetron. It showed a clinically relevant pain reducing effect in the temporomandibular region, both in a short- and long-term aspect.European Clinical Trials Database 2005-006042-41 as well as at Clinical Trials NCT02230371 .

SUBMITTER: Christidis N 

PROVIDER: S-EPMC4669334 | biostudies-literature | 2015

REPOSITORIES: biostudies-literature

altmetric image

Publications

Repeated tender point injections of granisetron alleviate chronic myofascial pain--a randomized, controlled, double-blinded trial.

Christidis Nikolaos N   Omrani Shahin S   Fredriksson Lars L   Gjelset Mattias M   Louca Sofia S   Hedenberg-Magnusson Britt B   Ernberg Malin M  

The journal of headache and pain 20151203


<h4>Background</h4>Serotonin (5-HT) mediates pain by peripheral 5-HT3-receptors. Results from a few studies indicate that intramuscular injections of 5-HT3-antagonists may reduce musculoskeletal pain. The aim of this study was to investigate if repeated intramuscular tender-point injections of the 5-HT3-antagonist granisetron alleviate pain in patients with myofascial temporomandibular disorders (M-TMD).<h4>Methods</h4>This prospective, randomized, controlled, double blind, parallel-arm trial (R  ...[more]

Similar Datasets

| S-EPMC6460974 | biostudies-literature
| S-EPMC8465617 | biostudies-literature
| S-EPMC2942821 | biostudies-other
| S-EPMC3697148 | biostudies-literature
| S-EPMC5688690 | biostudies-literature
| S-EPMC5520828 | biostudies-literature
| S-EPMC6433706 | biostudies-literature
| S-EPMC3978931 | biostudies-literature
| S-EPMC5386976 | biostudies-literature
| S-EPMC5124515 | biostudies-literature